We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday ...
Hosted on MSN21d
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing lossMedical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. The weight ...
Shares of Eli Lilly & Co. LLY slid 4.73% to $869.58 Friday, on what proved to be an all-around positive trading session for ...
Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...
Morgan Stanley analyst Terence Flynn notes that Novo Nordisk (NVO) reported CagriSema Phase 3 data in type two diabetes demonstrating weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback